ViaNautis (Formerly known as Somaserve) is building a uniquely positioned pharma service and specialist reagent business exploiting polyNautTM technology to image live cells and improve the therapeutic viability of molecules with poor pharmacokinetic and chemical properties.
Status | Active |
Website | https://www.vianautis.com/ |
Category | Pharmaceutical Enabler |
Modality | Small Molecule & Biological |
Headquaters | Cambridge, UK |
Partner | Abcam PLC |
Investment Portfolio | Fund Investment |
Co-Investors | 4BIO Capital, BGF and UCB Ventures, Cystic Fibrosis Foundation, Eli Lilly and Company, Origin Capital, Meltwind, Business Angels, Abcam PLC |